Natura Cosméticos (NATU3) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
2 Jul, 2026Executive summary
2024 saw significant progress in simplification, with Wave 2 integration completed in Brazil and ongoing in Mexico and Argentina, driving revenue and operational efficiencies.
Sale of Aesop and The Body Shop in 2023, further holding structure reduction, and completion of API's Chapter 11 in 2024 contributed to deleveraging.
Avon International remains under strategic review, with alternatives including sale or joint venture being considered, and ongoing restructuring.
Strong Q4-24 revenue momentum led by Natura brand in Brazil (+21.1%) and Hispanic Latam, but profitability impacted by higher investments in IT, marketing, and integration.
Q4-24 net loss narrowed sharply to BRL 439 million from BRL 2.7 billion in Q4-23, mainly due to non-operational adjustments and integration costs.
Financial highlights
FY24 consolidated net revenue was BRL 24.1 billion, up 12.4% YoY in constant currency; Q4-24 revenue reached BRL 7.7 billion, up 16.1% YoY in constant currency.
FY24 recurring EBITDA was BRL 2,935.7 million (margin 12.2%, +100 bps YoY); Q4-24 recurring EBITDA was BRL 703 million (margin 9.1%, down 70 bps YoY).
FY24 net loss was BRL 8.9 billion, mainly due to discontinued operations and non-recurring items.
Net debt at year-end was BRL 2.4 billion, with Net Debt/EBITDA at 1.27x; adjusted for non-operational effects, 0.86x.
Free cash flow from continuing operations in FY24 was BRL -126 million, with underlying free cash flow at BRL 931 million.
Outlook and guidance
Wave 2 integration to be completed in Mexico and Argentina by end of 2025, with further efficiency and margin gains expected.
Ongoing focus on expense control, margin expansion, and cash generation, especially in Latin America.
Transformation and integration costs to remain high in 2025 as programs ramp up in new countries.
Macro uncertainty in Brazil and potential beauty market slowdown are noted as risks for top-line growth.
Strategic review of Avon International continues, with focus on accelerated restructuring and cash outflow minimization.
Latest events from Natura Cosméticos
- Latam growth and margin gains drove Q1-25 revenue to BRL 6.7B, offsetting Avon's challenges.NATU3
Q1 20259 Jul 2026 - Core strengths, digitalization, and integration drive growth and profitability in Latin America.NATU3
Investor Day 20259 Jul 2026 - Recurring EBITDA up 52% YoY, but API deconsolidation drove a BRL 6.7bn net loss.NATU3
Q3 20248 Jul 2026 - Net revenues fell 7.7% YoY and net loss widened to BRL 445 million amid restructuring costs.NATU3
Q1 20267 Jul 2026 - Recurring EBITDA margin rose to 14.0% and net income turned positive amid major restructuring.NATU3
Q2 20256 Jul 2026 - Q3-25 revenue fell 13.1% YoY, with profitability pressured by macro and integration headwinds.NATU3
Q3 20256 Jul 2026 - Underlying EBITDA margin rose to 14.1% in FY25, with net income at BRL 974 million.NATU3
Q4 20256 Jul 2026 - Q2-24: Latam growth, margin gains, but a one-off tax hit led to a net loss.NATU3
Q2 20242 Jul 2026